Cleveland Diabetes Care

Cleveland Diabetes Care Focuses on Endocrine and Metabolic Systems in the Diabetes Drug MarketDiabetes affects millions of people worldwide. Current treatments available for these conditions are known to have significant limitations, which may lead to high rates of treatment discontinuation as well as unsatisfactory efficacy and safety profiles. Family members often face substantial challenges associated with the burden of these and many other endocrinological and metabolic diseases. Based on its understanding of the pathology of endocrine and metabolic disorders, pharmacological knowledge of its compound library, and anticipated outcomes addressing unmet patient needs, Cleveland Diabetes Care is pursuing new therapeutic options. The company’s candidate products all feature novel mechanisms of action, representing differentiated treatment choices, and are expected to meet unmet needs through significantly improved efficacy and safety.